RVMD vs. SHW
RVMD (Revolution Medicines, Inc.) and SHW (The Sherwin-Williams Company) are both stocks. RVMD operates in Biotechnology (Healthcare), while SHW operates in Specialty Chemicals (Basic Materials). Over the past 5 years, RVMD returned 35.73%/yr vs 4.52%/yr for SHW. At a 0.22 correlation, their price movements are largely independent.
Performance
RVMD vs. SHW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RVMD achieves a 100.95% return, which is significantly higher than SHW's -0.69% return.
RVMD
- 1D
- 4.02%
- 1M
- 9.89%
- YTD
- 100.95%
- 6M
- 102.61%
- 1Y
- 294.33%
- 3Y*
- 86.64%
- 5Y*
- 35.73%
- 10Y*
- —
SHW
- 1D
- 0.93%
- 1M
- 6.99%
- YTD
- -0.69%
- 6M
- -2.03%
- 1Y
- -3.77%
- 3Y*
- 9.88%
- 5Y*
- 4.52%
- 10Y*
- 13.83%
RVMD vs. SHW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
RVMD Revolution Medicines, Inc. | 100.95% | 82.10% | 52.51% | 20.40% | -5.36% | -36.42% | 40.34% |
SHW The Sherwin-Williams Company | -0.69% | -3.83% | 9.90% | 32.73% | -31.96% | 44.90% | 27.80% |
Correlation
The correlation between RVMD and SHW is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Feb 13, 2020 | 0.22 |
Fundamentals
RVMD:
$31.71B
SHW:
$79.45B
RVMD:
-$7.17
SHW:
$10.42
RVMD:
21.14
SHW:
17.93
RVMD:
$0.00
SHW:
$23.94B
RVMD:
-$4.70M
SHW:
$11.76B
RVMD:
-$1.34B
SHW:
$4.29B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RVMD vs. SHW — Risk / Return Rank
RVMD
SHW
RVMD vs. SHW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines, Inc. (RVMD) and The Sherwin-Williams Company (SHW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RVMD | SHW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.57 | ||
| Sortino ratioReturn per unit of downside risk | +5.64 | ||
| Omega ratioGain probability vs. loss probability | 1.78 | 0.99 | +0.79 |
| Calmar ratioReturn relative to maximum drawdown | 11.88 | -0.18 | +12.06 |
| Martin ratioReturn relative to average drawdown | 28.48 | -0.37 | +28.85 |
Loading charts...
Drawdowns
RVMD vs. SHW - Drawdown Comparison
The maximum RVMD drawdown since its inception was -73.29%, which is greater than SHW's maximum drawdown of -52.02%. Use the drawdown chart below to compare losses from any high point for RVMD and SHW.
Loading charts...
Drawdown Indicators
| RVMD | SHW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.29% | -52.02% | -21.27% |
Max Drawdown (1Y)Largest decline over 1 year | -24.95% | -21.36% | -3.59% |
Max Drawdown (3Y)Largest decline over 3 years | -48.63% | -25.69% | -22.94% |
Max Drawdown (5Y)Largest decline over 5 years | -57.95% | -42.46% | -15.49% |
Max Drawdown (10Y)Largest decline over 10 years | — | -42.46% | — |
Current DrawdownCurrent decline from peak | -2.21% | -18.78% | +16.57% |
Average DrawdownAverage peak-to-trough decline | -35.66% | -11.63% | -24.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.57% | 10.26% | +0.31% |
Volatility
RVMD vs. SHW - Volatility Comparison
Revolution Medicines, Inc. (RVMD) has a higher volatility of 13.97% compared to The Sherwin-Williams Company (SHW) at 9.00%. This indicates that RVMD's price experiences larger fluctuations and is considered to be riskier than SHW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RVMD | SHW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.97% | 9.00% | +4.97% |
Volatility (6M)Calculated over the trailing 6-month period | 55.20% | 19.26% | +35.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 67.30% | 24.88% | +42.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.58% | 26.27% | +36.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 65.75% | 26.60% | +39.15% |
Dividends
RVMD vs. SHW - Dividend Comparison
RVMD has not paid dividends to shareholders, while SHW's dividend yield for the trailing twelve months is around 0.99%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RVMD Revolution Medicines, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SHW The Sherwin-Williams Company | 0.99% | 0.98% | 0.84% | 0.78% | 1.01% | 0.62% | 0.73% | 0.77% | 0.87% | 0.83% | 1.25% | 1.03% |
Financials
RVMD vs. SHW - Financials Comparison
This section allows you to compare key financial metrics between Revolution Medicines, Inc. and The Sherwin-Williams Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RVMD and SHW have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RVMD has higher volatility (13.97%) compared to SHW (9.00%). In terms of maximum drawdown, RVMD dropped -73.29% vs SHW's -52.02%.
RVMD currently has the higher Sharpe Ratio (4.41 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RVMD and SHW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer